NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email OpenAI reportedly added 1 million paying business subscribers since February. Those additions lifted the number of such subscribers from two million inRead More